JUN and non-small cell lung carcinoma: For example, miR-760 boosts TRAIL sensitivity in non-small cell lung cancer through reducing the protein FOXA1 [19]; miR-760 suppresses human colorectal cancer growth by targeting BATF3/AP-1/cyclinD1 signaling [20].